Topical Drugs Ability to Help Replace Brain Cells Lost From Multiple Sclerosis
Link: https://www.sciencedaily.com/releases/2015/04/150420111357.htm
The highly informative journal
article written in Science Daily involves a team of scientists utilizing a new
discovery approach to identify drugs which possess the capability of activating
mouse brain stem cells. Fascinatingly
the two topical drugs, Miconazole and Clobetasol; one is used to treat athletes
foot and the other is used to treat eczema, were discovered to be able to
stimulate the regeneration of damaged brain cells and reverse the effects of
muscular paralysis in animal models of multiple sclerosis. As a result, the
team of scientists believe that the two topical drugs could potentially be
utilized in the future to effectively treat individuals afflicted with multiple
sclerosis. The researchers’ objective was to identify drugs that could
reproduce the body’s own stem cells as a means of replacing the damaged cells
caused by multiple sclerosis.
The drugs discovered,could potentially rebuild
damaged brain cells caused by multiple sclerosis. The multiple sclerosis
disease involves the damaging of immune cells and the destruction of protective
myelin around nerve cells in the brain and spinal cord. The two topical drugs
have the ability to stimulate the body’s own stem cells as a means of
formulating new myelin. A representative of the national center for
regenerative medicine, Tesar discovered a method of reproducing large amounts
of a special type of stem cell known as oligodendrocyte progenitor cells (OPC)
which are typically found throughout the brain and spinal cord. As a result of
this finding, Tesar and his team of scientists began testing different drugs in
order to identify which drugs could stimulate the OPC’s as a means of
generating new myelin. This led them to discover that the topical medications
of Miconazole and Clobetasol possessed a capability of stimulating OPC’s as a
means of formulating novel myelin. The scientists conducted an experiment
involving exposing the two topical medications of Miconazole and Clobetasol to
lab mice suffering from a multiple sclerosis-like disease which caused the OPC’s
within the brain and spinal cord of the mice to rebuild new myelin. As a
result, the damaged brain cells in the mice began to reformulate which helped
effectively treat the mice after suffering from the debilitating symptoms
associated with multiple sclerosis.
Scientists
need to now identify methods on how to make the two topical medications work
for internal use, determine the medications long term effects, and any
potential side effects before individuals suffering from multiple sclerosis can
benefit from the treatment. As a result, scientists estimate that the two
topical medications will not be able to be effectively utilized to treat
patients suffering from multiple sclerosis for several more years but when the
topical drugs are approved, they will create a huge advancement in regenerating
damaged and lost brain cells in individuals’ afflicted with multiple sclerosis
disorder. Additionally, researchers exposed the two topical medications to
damaged human stem cells and found out that the medication helped to rebuild
new myelin and regenerate the brain cells, which contributes to one of the many
reasons we need for more human research trials to be performed in the future.
Scientific researchers are now planning to enhance their understanding as to
why these two topical medications work to formulate new myelin as a means of
modifying the drugs in order to increase their effectiveness in treating
individuals afflicted with multiple sclerosis disorder. The two topical
medications of Miconazole and Clobetasol can also be utilized to treat several problematic
disorders involved in myelin depletion which include cerebral palsy, dementia,
and schizophrenia.
Upon reading this article, I felt extremely
satisfied that leading scientists are conducting research on methods to help
rebuild myelin and regenerate brain cells that are destroyed or damaged in individuals
afflicted with multiple sclerosis disorder. I strongly believe that multiple
sclerosis disorder is one of the worst motor neuron deficient disorders because
I learned in the class lecture on movement, that due to multiple sclerosis
destroying protective myelin around nerve cells in the brain and spinal cord,
the neural signals within the brain experience severe disruptions in their
transmissions along nerves. As a result, this causes devastating permanent
effects on the brain’s ability to initiate movements over time and it also
causes individuals to have severe motor functioning difficulties on a permanent
basis. I really connected to
this article and the research findings because I recently learned about
multiple sclerosis in the movement chapter so I have a good understanding on
the dangerous demyelination process involving the slowing down or elimination of
neural impulses which causes an overall reduction in speed and reduction in
strength of movements in individuals afflicted with multiple sclerosis disorder. As a result, I really
support the research and scientific work that Dr. Tesar and the national center
for regenerative medicine are conducting. I strongly feel that more government
funding should be given to this scientific research because I feel that further
extensive research will allow scientists to figure out how to transform the two
topical medications to function for internal use in human multiple sclerosis.
Comments
Post a Comment